Cardiovascular disease (CVD) and stroke are two of the leading causes of morbidity and mortality among adults in North America and are strongly determined by levels of common CVD risk factors including hypertension, diabetes, obesity, cigarette smoking, and dyslipidemia. Specific extracellular RNAs regulate key processes central to the pathogenesis of CVD and several small human studies have associated extracellular RNAs with specific forms of CVD. We postulate that the expression of plasma RNAs change over time and is influenced by the duration and intensity of exposure to CVD risk factors, relates to subclinical atherosclerosis phenotypes, and will therefore be useful predictors of incident CVD events. We intend to further explore and validate the diagnostic and prognostic utility of extracellular RNAs associated with CVD and preclinical CVD phenotypes in our community-based cohort study in a hospitalized sample with acute coronary syndromes. To accomplish these aims, in the U2 phase of our study we will use an optimized non-commercial isolation method for high-yield plasma RNA extraction as well as high-throughput sequencing to identify known and as-yet undiscovered extracellular circulating RNAs, thereby developing a broad panel of plasma-derived extracellular RNA biomarkers (including miRNA, piRNA, noncoding RNAs) to screen 2914 participants in the Framingham Heart Study (FHS) Study (Offspring Exam 8). In the U3 phase of the application, we will further evaluate changes in circulating RNAs over time and in relation to incident CVD and disease progression, by screening the same individuals 5 years later (Offspring Exam 9). We will then examine associations between extracellular RNAs and CVD-related prognosis in ~400 participants of TRACE-CORE (Transitions and Research in Acute Coronary Events - Center for Outcomes Research and Education). We will perform exploratory analyses to determine if these methods can be extended to non-CVD populations. Last, we will partner with industry leaders to develop a quick and effective point-of-care test for extracellular RNA profiles associated with disease.

Public Health Relevance

Specific RNAs found in the circulation outside of cells may regulate key processes that influence the development of disease and/or be markers of its presence or progression. Cardiovascular disease is a leading cause of morbidity and mortality among adults in North America. Using currently available plasma samples from several well-characterized observational and patients populations extending beyond cardiac syndromes, these two projects aim to define the expression of circulating RNAs in health and disease.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Exploratory/Developmental Cooperative Agreement Phase I (UH2)
Project #
1UH2TR000921-01
Application #
8581770
Study Section
Special Emphasis Panel (ZRG1-GGG-R (51))
Program Officer
Tagle, Danilo A
Project Start
2013-08-01
Project End
2015-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
1
Fiscal Year
2013
Total Cost
$500,000
Indirect Cost
$199,700
Name
University of Massachusetts Medical School Worcester
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Tanriverdi, Kahraman; Kucukural, Alper; Mikhalev, Ekaterina et al. (2016) Comparison of RNA isolation and associated methods for extracellular RNA detection by high-throughput quantitative polymerase chain reaction. Anal Biochem 501:66-74
Shah, Ravi; Pico, Alexander R; Freedman, Jane E (2016) Translational Epidemiology: Entering a Brave New World of Team Science. Circ Res 119:1060-1062
Sardana, Mayank; Ogunsua, Adedotun A; Spring, Matthew et al. (2016) Association of Left Atrial Function Index With Late Atrial Fibrillation Recurrence after Catheter Ablation. J Cardiovasc Electrophysiol 27:1411-1419
Henninger, Nils; Goddeau Jr, Richard P; Karmarkar, Ameeta et al. (2016) Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes. Stroke 47:1486-92
Shah, Ravi; Tanriverdi, Kahraman; Levy, Daniel et al. (2016) Discordant Expression of Circulating microRNA from Cellular and Extracellular Sources. PLoS One 11:e0153691
McManus, David D; Saczynski, Jane S; Lessard, Darleen et al. (2016) Reliability of Predicting Early Hospital Readmission After Discharge for an Acute Coronary Syndrome Using Claims-Based Data. Am J Cardiol 117:501-7
Clancy, Lauren; Freedman, Jane E (2016) Blood-Derived Extracellular RNA and Platelet Pathobiology: Adding Pieces to a Complex Circulating Puzzle. Circ Res 118:374-6
Soni, Apurv; Earon, Allison; Handorf, Anna et al. (2016) High Burden of Unrecognized Atrial Fibrillation in Rural India: An Innovative Community-Based Cross-Sectional Screening Program. JMIR Public Health Surveill 2:e159
Freedman, Jane E; Gerstein, Mark; Mick, Eric et al. (2016) Diverse human extracellular RNAs are widely detected in human plasma. Nat Commun 7:11106
Huan, Tianxiao; Rong, Jian; Liu, Chunyu et al. (2015) Genome-wide identification of microRNA expression quantitative trait loci. Nat Commun 6:6601

Showing the most recent 10 out of 20 publications